being held in San Francisco and were featured in a CROI press conference. Merck plans to begin submitting applications for marketing authorization to regulatory agencies by mid-2025. In the double ...

In a presentation at JPMorgan’s healthcare investment conference in San Francisco late Monday, Merck executives presented a rosy picture as the company heads toward the 2028 patent expiration.

Merck (MRK) announced the presentation of “positive” results from two pivotal Phase 3 trials of the investigational, once-daily, oral, two-drug ...

Merck and the plaintiff plan to reconvene in ... a professor at UC Law San Francisco who specializes in legal and policy issues related to vaccines. Robi, 30, was vaccinated with Gardasil as ...

US pharma giant Merck & Co (NYSE: MRK) has presented positive results from two pivotal Phase III trials of the ...

Merck (NYSE:MRK) is preparing to launch a subcutaneously ... Davis on Monday at the JPMorgan Healthcare Conference in San Francisco. "That's actually new information and an acceleration from ...

Merck & Co is among the partners behind a consortium ... Hannan Parvisian, CEO and co-founder of San Francisco-based Volans-i, said: “Successfully demonstrating our ability to make temperature ...

Merck Animal Health and AASVF awarded $50,000 in scholarships to five veterinary students pursuing careers in swine health.

Exclusive-Merck Vaccine Case Linked to HHS Secretary ... a professor at UC Law San Francisco who specializes in legal and policy issues related to vaccines. Robi, 30, was vaccinated with Gardasil ...